NewLink Genetics - NLNK - close: 23.50 change: +0.08

Stop Loss: 21.90
Target(s): 27.50
Current Gain/Loss: unopened

Entry on December -- at $--.--
Listed on December 26, 2013
Time Frame: 6 to 8 weeks
Average Daily Volume = 219 thousand
New Positions: Yes, see below

Company Description

Why We Like It:
NLNK is in the healthcare sector. The company operates in the biotech field. They focus on cancer treatments using immunotherapeutic products.

Biotech stocks have been strong performers this year. NLNK is no exception. However, biotech stocks can be hazardous to trade. The wrong headline about some failed clinical trial or a set back with the FDA approval process can send biotech stocks crashing. If you're tempted to trade a stock like NLNK do so cautiously.

I consider this an aggressive, higher-risk trade. Shares are currently trading near their all-time highs set back in June 2013. I am suggesting a trigger to launch small bullish positions at $23.80. If triggered our target is $27.50 but you may want to aim higher. There is a chance that NLNK could see a short squeeze. The most recent data listed short interest at 22% of the very small 15.2 million share float.

Trigger @ 23.80 *small positions*

Suggested Position: buy NLNK stock @ (trigger)

Annotated chart: